Altre lingue WuXi AppTec Co., Ltd.

Azioni

603259

CNE1000031K4

Biotecnologia

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 12/12/2025			Variaz. 5gg	Var. 1 gen.
94,05 ^CNY	+0,70%		+4,04%	+70,88%

28/11	WUXI APPTEC CO., LTD. : Nomura ancora positivo	ZM
28/11	WUXI APPTEC CO., LTD. : Nomura rimane Buy	ZM

Altre lingue

Traders Await Fresh Catalysts; Asian Stock Markets Churn	28/11
Pentagon Cites Eight Chinese Companies for Military Aid	27/11
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year Recognition in the CRDMO Industry	21/11
BlackRock's long position in H-shares of Wuxi Apptec increases to 5.48% on Nov 5 - HKEX	10/11
Wuxi Apptec's shareholders to cut 2% A-shares	29/10
Neom signs strategic MoU with Wuxi Apptec to advance Saudi's biotechnology sector	28/10
Wuxi Apptec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic Mous with Neom and Ministry of Health	28/10
Chinese Pharma Firm WuXi AppTec Shares Rise After Strong Results, Guidance Raise	27/10
WuXi AppTec Books 53% Higher Profit in Q3; Agrees to Sell Two Units to Hillhouse Investment	27/10
WuXi AppTec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	26/10
WuXi AppTec : Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025; Backlog for Continuing Operations Up 41.2% YoY; Further Raises 2025 Full-year Guidance	26/10
WuXi AppTec : Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025; Backlog for Continuing Operations Up 41.2% YoY Further Raises 2025 Full-year Guidance	26/10
WuXi AppTec : Unveils Modernized Logo, Reflecting Continued Evolution as a Global Healthcare Partner	26/10
WuXi AppTec : 2025 Third Quarterly Results Presentation	26/10
WuXi AppTec : Signs Definitive Agreement to Sell China-based Clinical Research Services Business to Hillhouse	26/10
WuXi AppTec's unit plans asset sales	26/10
WuXi AppTec Co., Ltd. Raises Earnings Guidance for They Full Year 2025	26/10
Wuxi Apptec's Q3 net profit up 53.3% Y/Y	26/10
Bourse : Safran, Sanofi et Accor assurent, Intel séduit, Mersen tangue	24/10
L'inflation fait son grand retour (dans l'agenda)	24/10
BlackRock Inc's long position in H-shares of Wuxi Apptec decreases to 4.50% on Oct 16 from 5.15% - HKEX	22/10
Shandong Buchang Pharmaceuticals Unit Signs 11-Million-Yuan Technical Service Contract	17/10
I-Mab Announces Chief Financial Officer Changes, Effective October 16, 2025	16/10
JPMorgan's long position in H-shares of Wuxi Apptec decreases to 5.59% on Oct 10, HKEX filing shows	15/10
BIOSECURE Included In Draft National Defense Authorization Act Of 2026	14/10

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue WuXi AppTec Co., Ltd.

Azioni

603259

CNE1000031K4

Biotecnologia

Altre lingue

Filtri